Joint Effect of CFH and ARMS2/HTRA1 Polymorphisms on Neovascular Age-Related Macular Degeneration in Chinese Population

Table 1

Inclusion and exclusion criteria.

	Inclusion criteria	Exclusion criteria
nAMD patients	(i) Being of age 50 years or more; (ii) Having no signs of other retina diseases; (iii) Having neovascular AMD; (iv) Having DNA samples for genotyping	(i) Polypoidal choroidal vasculopathy (PCV); (ii) Myopia of 6.00 diopters or above; (iii) Macular nutrition disabilities; (iv) Central serous chorioretinopathy; (v) Any kind of vein occlusion; (vi) Diabetic retinopathy; (vii) Pigment phlogistic; (viii) Other diseases involving malfunction of retinal photoreceptor cells
Controls	(i) Being of age 50 years or more; (ii) Being confirmed negative of AMD with fundus examination; (iii) Having DNA samples for genotyping	(i) Participants with too serious chronic diseases to complete questionnaire and examinations